Furthermore, in patients with decompensated cirrhosis, GH treatment in conjunction with standard medical therapy has shown beneficial effects across various parameters, including skeletal muscle index, liver frailty index, and Child-Turcotte-Pugh score for end-stage liver disease (23). The gene discussed is GH1; the disease is Cirrhosis.